AGENUS INC — Investor Relations & Filings
Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46361646 | 8-K | 2026-05-15 | English | ||
| 45001328 | 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 44960365 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 39218368 | DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | ||
| 33051679 | SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | ||
| 33048504 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English | ||
| 32887479 | 4 - AGENUS INC (0001098972) (Filer) | 2026-02-24 | English | ||
| 27360653 | 4 Filing | 2026-02-09 | English | ||
| 27360005 | 4 Filing | 2026-01-26 | English | ||
| 27360607 | SCHEDULE 13D Filing | 2026-01-23 | English | ||
| 27360811 | 8-K Filing | 2026-01-16 | English | ||
| 27360755 | 3 Filing | 2026-01-16 | English | ||
| 27359870 | 8-K Filing | 2026-01-14 | English | ||
| 27360545 | 4 Filing | 2026-01-12 | English | ||
| 27359929 | 8-K Filing | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AGENUS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34023/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34023 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34023 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34023 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34023}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AGENUS INC (id: 34023)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.